Evidence map›Paper›PMID 32661847›Full record

ArticleAnnals of surgical oncology2021

Orthopedic Surgical Treatment and Perioperative Complications in Multiple Myeloma Bone Disease: Analysis of a Series (2009-2018).

María Galán-Olleros, Javier Marco, David Oteo, Rafael Cristóbal-Bilbao, Elena Manrique, Roberto García-Maroto, Fernando Marco, Juan Luis Cebrián-Parra

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Cancers · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

María Galán-OllerosOncological Traumatology Unit, Department of Traumatology and Orthopedic Surgery, Hospital Clínico San Carlos, Madrid, Spain. mgalanolleros@gmail.com.ORCID http://orcid.org/0000-0001-9074-9215
Javier MarcoDepartment of Internal Medicine, Hospital Clínico San Carlos, Madrid, Spain.
David OteoDepartment of Internal Medicine, Hospital Clínico San Carlos, Madrid, Spain.
Rafael Cristóbal-BilbaoDepartment of Internal Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain.
Elena ManriqueOncological Traumatology Unit, Department of Traumatology and Orthopedic Surgery, Hospital Clínico San Carlos, Madrid, Spain.
Roberto García-MarotoOncological Traumatology Unit, Department of Traumatology and Orthopedic Surgery, Hospital Clínico San Carlos, Madrid, Spain.
Fernando MarcoOncological Traumatology Unit, Department of Traumatology and Orthopedic Surgery, Hospital Clínico San Carlos, Madrid, Spain.
Juan Luis Cebrián-ParraOncological Traumatology Unit, Department of Traumatology and Orthopedic Surgery, Hospital Clínico San Carlos, Madrid, Spain.
Hospital Clínico San Carlos · ESHospital Universitario de Fuenlabrada · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMore than 90% of patients with multiple myeloma (MM) develop lytic bone lesions that can be surgically treated for symptomatic relief and functional improvement.

methodsThis was a retrospective observational analytic study conducted between 2009 and 2018, including 58 patients with MM bone disease who underwent 77 orthopedic surgical procedures and were co-managed by internal medicine. Analysis of data related to MM bone disease, different modalities of surgical treatment, perioperative complications, and survival was performed.

resultsMedian age was 72 years (66.5-77 years) and 56.9% of patients were males; 54.43% of injuries were located in the spine, 27.85% in the pelvis or lower limbs, 15.19% in the upper limbs, and 75.32% of patients had pathologic fractures. In 29.31% of the cases, the bone lesion was the debut of MM. Surgical procedures performed were mainly kyphoplasty (48.05%) and intramedullary nailing (29.87%). The overall complication rate following surgery was 74.03%. Only 20.78% of cases had a surgical complication. Among medical complications, we registered 28.57% transfusion requirements, 25.97% acute renal failures, 24.68% developed an infection, and 10.39% developed hypercalcemia. Patients were followed-up for a mean of 6.13 years and 37.93% suffered a new fracture. The median overall survival time for patients after surgery was 32.9 months (11.6-49). The estimated overall survival at 1, 3, and 5 years after surgery was 81.17%, 57%, and 34.11%, respectively.

conclusionsThe orthopedic surgical treatment of MM bone disease aims to improve symptomatology and patient quality of life; however, these patients have a high risk of perioperative complications and considerable early mortality, making multidisciplinary management with medical specialties essential.

Indexed as

Bone DiseasesMultiple MyelomaAgedHumansMaleQuality of LifeRetrospective StudiesTreatment Outcome

Identifiers

PMID32661847
OpenAlexW3041549506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.